Capital efficiency slipping
ROCE has fallen for 3 consecutive years, from 52.7% to 35.5%.
Importance 59 / 95 · profitability
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
ROCE has fallen for 3 consecutive years, from 52.7% to 35.5%.
Importance 59 / 95 · profitability
ROE of 27.1% is well above the speciality retail median of 16.4%.
Importance 53 / 95 · profitability
EBITDA margin of 18.9% is the widest in 4 years (prior range 16.2% to 17.9%).
Importance 52 / 95 · profitability
Classified by the exchange under Consumer Discretionary › Consumer Services › Retailing › Speciality Retail.
Peer set used on this page: 2 speciality retail.
Revenue grew 50.1% a year over 4 years, from ₹3,881 cr in FY2022 to ₹19,701 cr in FY2026. Net profit grew 67.6% a year over the same period.
Net profit grew 12.2% year on year (FY2025 → FY2026).
Rule PROFIT_GREW_YOY
Revenue grew 17.2% year on year (FY2025 → FY2026).
In Q2 FY27 (Jul–Sep 2026), revenue was ₹5,873 cr (up 21.9% on the same quarter last year) and net profit ₹468 cr (up 25.4%).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q2 FY27 net profit was ₹468 cr, up 25.4% from ₹373 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q2 FY27 revenue was ₹5,873 cr, up 21.9% from ₹4,818 cr in Q2 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Q2 FY27 EBIT was ₹684 cr, up 31.7% from ₹520 cr a year earlier.
Rule QTR_OPERATING_PERFORMANCE_CHANGE_YOY
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q3 FY25 | 4,657 | +34.3% | 497 | +34.0% | 10.7% |
| Q4 FY25 | 4,217 | +27.9% | 312 | −56.2% | 7.4% |
| Q1 FY26 | 4,883 | +19.0% | 425 | +8.6% | 8.7% |
| Q2 FY26 | 4,818 | +15.9% | 373 | +11.4% | 7.8% |
| Q3 FY26 | 5,345 | +14.8% | 510 | +2.7% | 9.5% |
| Q4 FY26 | 5,028 | +19.2% | 413 | +32.6% | 8.2% |
| Q1 FY27 | 5,755 | +17.8% | 518 | +22.0% | 9.0% |
| Q2 FY27 | 5,873 | +21.9% | 468 | +25.4% | 8.0% |
Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters
EBITDA margin was 20.4% in FY2026, against 23.5% in FY2022. ROE was 28.9% and ROCE 37.0% in FY2026.
ROCE has fallen for 3 consecutive years, from 52.7% to 35.5%.
Rule ROCE_DECLINING_STREAK
ROE of 27.1% is well above the speciality retail median of 16.4%.
EBITDA margin of 18.9% is the widest in 4 years (prior range 16.2% to 17.9%).
ROE declined from 31.7% to 27.1% year on year.
Debt-to-equity was 0.06x in FY2026, against 0.18x in FY2022; interest coverage 16.40x. Operating cash flow was 1.34x net profit.
Free cash flow has been positive in 4 of the last 5 years.
Rule FCF_CONSISTENTLY_POSITIVE
Its peer group is too small for a meaningful ranking.
Ranked against 2 speciality retail (FY2026, consolidated).
Not enough peers in this set report the underlying metrics yet for a ranking.
Trades at 60.55× earnings — 46% below the speciality retail median of 111.35×.
Rule PE_BELOW_PEERS
On the trailing twelve months. Last full year: P/E 67.2× · P/S 5.7× · ROE 27.1%.
The share price is up 11.2% over 1 year, up 86.6% over 3 years (23.1% a year) and up 329% over 5 years (33.8% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is 2.7% below its 52-week high.
Over 3 years profit compounded at 63.5% a year while the stock returned 23.1% a year — but FY2023 profit (₹394) was well below the through-cycle level (~₹1,506), so this rate is inflated by the recovery from a low base.
Rule STOCK_LAGGED_EARNINGS · recovery
Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 3,881 | 7,715 | 11,927 | 16,668 | 19,701 |
| Total income | 4,160 | 8,127 | 12,277 | 16,997 | 20,076 |
| EBITDA | 913 | 1,531 | 2,278 | 3,083 | 4,018 |
| Profit before tax | 323 | 711 | 1,873 | 2,077 | 2,512 |
| Net profit | 250 | 555 | 1,436 | 1,585 | 1,968 |
| EPS (₹) | 7.0 | 15.6 | 40.4 | 44.6 | 55.4 |
| Net worth | 2,720 | 3,080 | 4,447 | 5,914 | 7,703 |
| Total debt | 497 | 698 | 499 | 499 | 500 |
| Operating cash flow | 578 | 663 | 1,348 | 1,668 | 2,630 |
| Free cash flow | 380 | 168 | 966 | 851 | 1,143 |
| Ratio | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue growth YoY | — | 98.8 | 54.6 | 39.8 | 18.2 |
| Profit growth YoY | — | 122.2 | 158.9 | 10.4 | 24.2 |
| Profitability | |||||
| EBITDA margin % | 23.5 | 19.8 | 19.1 | 18.5 | 20.4 |
| Net margin % | 6.0 | 6.8 | 11.7 | 9.3 | 9.8 |
| Return on equity % | 9.2 | 19.1 | 38.2 | 30.6 | 28.9 |
| Return on capital % | 19.6 | 30.5 | 37.6 | 39.0 | 37.0 |
| Leverage & cash | |||||
| Debt to equity | 0.18 | 0.23 | 0.11 | 0.08 | 0.06 |
| Cash flow ÷ profit | 2.31 | 1.20 | 0.94 | 1.05 | 1.34 |
| Current ratio | 2.86 | 2.12 | 1.96 | 1.76 | 1.23 |